Pharmaceutical US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) responded to the US Patent and Trademark Office’s (USPTO) request for comments regarding the USPTO initiatives to “bolster the robustness and reliability of patents” and “ensure that the patent rights granted by the USPTO fulfill their intended purpose of furthering the common good, incentivizing innovation, and promoting economic prosperity.” 25 February 2023